Mayo Clinic researchers identify testing for patients for prostate ...( w rate residual urinary volume and pro...),Health

Others involved in the study were: Scott Lisson, M.D., Gregory Broderick, M.D., Paul Young, M.D. and Todd Igel, M.D., of the Mayo Clinic Department of Urology, and Steven Buskirk, M.D., of the Mayo Clinic Department of Radiation Oncology.

In an editorial in the same issue, Igor Frank, M.D., and Michael Blute, M.D., of Mayo Clinics Department of Urology say this study provides an important step in helping physicians inform patients about the risk of severe urinary difficulties associated with brachytherapy.

"As the number of treatment options expands, the need for evidence-based stratification tools increases," they write. "Such data-based tools would enable the clinician and patient to identify treatment choices associated with the least morbidity, without altering rates of disease control, on the basis of the patient's individual anatomical and physiological characteristics." Once these tools are established, patients can be directed toward therapies that are least likely to negatively affect their quality of life.

'"/>

Contact: John Murphy
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
9-Mar-2004